OBJ signs research agreement with GlaxoSmithKline Healthcare

Pharmaceutical giant GlaxoSmithKline Consumer Healthcare has signed a short term arrangement with Leederville-based transdermal drug delivery company OBJ Ltd to carry out studies into the use of its technology on a range of nonprescription applications.